Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 1
1988 2
1989 4
1991 1
1992 3
1993 2
1994 3
1995 2
1996 2
1997 4
1998 2
1999 2
2000 2
2001 2
2002 1
2003 3
2004 3
2005 2
2006 2
2007 2
2008 1
2009 5
2010 3
2011 2
2013 1
2015 1
2020 3
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

61 results

Results by year

Filters applied: . Clear all
Page 1
Preclinical characterization of the Toll-like receptor 7/8 antagonist MHV370 for lupus therapy.
Hawtin S, André C, Collignon-Zipfel G, Appenzeller S, Bannert B, Baumgartner L, Beck D, Betschart C, Boulay T, Brunner HI, Ceci M, Deane J, Feifel R, Ferrero E, Kyburz D, Lafossas F, Loetscher P, Merz-Stoeckle C, Michellys P, Nuesslein-Hildesheim B, Raulf F, Rush JS, Ruzzante G, Stein T, Zaharevitz S, Wieczorek G, Siegel R, Gergely P, Shisha T, Junt T. Hawtin S, et al. Among authors: raulf f. Cell Rep Med. 2023 May 16;4(5):101036. doi: 10.1016/j.xcrm.2023.101036. Cell Rep Med. 2023. PMID: 37196635 Free PMC article.
[Haemorrhoidal suffering].
Pühse G, Raulf F. Pühse G, et al. Among authors: raulf f. Urologe A. 2007 Mar;46(3):W303-14; quiz W315. doi: 10.1007/s00120-006-1281-6. Urologe A. 2007. PMID: 17294153 Review. German.
Molecular pharmacology of somatostatin-receptor subtypes.
Bruns C, Weckbecker G, Raulf F, Kaupmann K, Schoeffter P, Hoyer D, Lübbert H. Bruns C, et al. Among authors: raulf f. Ann N Y Acad Sci. 1994 Sep 15;733:138-46. doi: 10.1111/j.1749-6632.1994.tb17263.x. Ann N Y Acad Sci. 1994. PMID: 7978861 Review. No abstract available.
Binding properties of somatostatin receptor subtypes.
Bruns C, Raulf F, Hoyer D, Schloos J, Lübbert H, Weckbecker G. Bruns C, et al. Among authors: raulf f. Metabolism. 1996 Aug;45(8 Suppl 1):17-20. doi: 10.1016/s0026-0495(96)90072-4. Metabolism. 1996. PMID: 8769372 Review.
Characterization of somatostatin receptor subtypes.
Bruns C, Weckbecker G, Raulf F, Lübbert H, Hoyer D. Bruns C, et al. Among authors: raulf f. Ciba Found Symp. 1995;190:89-101; discussion 101-10. doi: 10.1002/9780470514733.ch6. Ciba Found Symp. 1995. PMID: 7587655 Review.
Somatostatin analogs for diagnosis and treatment of cancer.
Weckbecker G, Raulf F, Stolz B, Bruns C. Weckbecker G, et al. Among authors: raulf f. Pharmacol Ther. 1993 Nov;60(2):245-64. doi: 10.1016/0163-7258(93)90009-3. Pharmacol Ther. 1993. PMID: 7912834 Review.
Pharmacodynamics in the development of new immunosuppressive drugs.
Burkhart C, Heusser C, Morris RE, Raulf F, Weckbecker G, Weitz-Schmidt G, Welzenbach K. Burkhart C, et al. Among authors: raulf f. Ther Drug Monit. 2004 Dec;26(6):588-92. doi: 10.1097/00007691-200412000-00002. Ther Drug Monit. 2004. PMID: 15570181 Review.
Fecal incontinence: part 4 of a series of articles on incontinence.
Probst M, Pages H, Riemann JF, Eickhoff A, Raulf F, Kolbert G. Probst M, et al. Among authors: raulf f. Dtsch Arztebl Int. 2010 Aug;107(34-35):596-601. doi: 10.3238/arztebl.2010.0596. Epub 2010 Aug 20. Dtsch Arztebl Int. 2010. PMID: 20838452 Free PMC article. Review.
Immunosuppressive FK506 treatment leads to more frequent EBV-associated lymphoproliferative disease in humanized mice.
Caduff N, McHugh D, Murer A, Rämer P, Raykova A, Landtwing V, Rieble L, Keller CW, Prummer M, Hoffmann L, Lam JKP, Chiang AKS, Raulf F, Azzi T, Berger C, Rubic-Schneider T, Traggiai E, Lünemann JD, Kammüller M, Münz C. Caduff N, et al. Among authors: raulf f. PLoS Pathog. 2020 Apr 6;16(4):e1008477. doi: 10.1371/journal.ppat.1008477. eCollection 2020 Apr. PLoS Pathog. 2020. PMID: 32251475 Free PMC article.
Adriforant is a functional antagonist of histamine receptor 4 and attenuates itch and skin inflammation in mice.
Uluckan Ö, Bruno S, Wang Y, Wack N, Wilzopolski J, Goetschy JF, Delucis-Bronn C, Urban B, Fehlmann D, Stark H, Hauchard A, Roussel E, Kempf D, Kaupmann K, Raulf F, Bäumer W, Röhn TA, Zerwes HG. Uluckan Ö, et al. Among authors: raulf f. Eur J Pharmacol. 2023 Apr 15;945:175533. doi: 10.1016/j.ejphar.2023.175533. Epub 2023 Jan 21. Eur J Pharmacol. 2023. PMID: 36690055
61 results